From: The epidemiology of herpes zoster and its complications in Medicare cancer patients
Outcome Measure | First events | Population1 | % with herpes zoster-related pain |
---|---|---|---|
All Cancer | 27,664 | 66,222 | 41.8 |
Hematologic Cancers 2 | 3,611 | 7,574 | 47.7 |
Chronic Lymphocytic Leukemia | 914 | 1,754 | 52.1 |
Acute Lymphocytic or Acute Myeloid Leukemia | 79 | 257 | 30.7 |
Other Leukemia | 161 | 391 | 41.2 |
Hodgkin’s Lymphoma | 133 | 283 | 47.0 |
Non-Hodgkin’s Lymphoma | 2,324 | 4,891 | 47.5 |
Solid Cancers 2 | 24,070 | 58,670 | 41.0 |
Bladder Cancer | 1,716 | 4,140 | 41.4 |
Breast Cancer | 6,822 | 15,819 | 43.1 |
Colorectal Cancer | 3,010 | 7,354 | 40.9 |
Head and Neck Cancer | 1,030 | 2,530 | 40.7 |
Lung Cancer | 2,495 | 6,376 | 39.1 |
Melanoma | 1,666 | 3,961 | 42.1 |
Ovarian Cancer | 343 | 844 | 40.6 |
Prostate Cancer | 6,847 | 17,371 | 39.4 |
Soft Tissue Sarcoma | 141 | 275 | 51.3 |